title: Clinical use of immune serum globulin as replacement therapy in patients with primary immunodeficiency syndromes.
abstract: IVIG is the definitive therapy for primary immunodeficiency diseases associated with hypogammaglobulinemia or specific antibody deficiencies. Administration of IVIG is relatively safe, but occasional adverse reactions are usually self-limited and generally are not an indication for stopping therapy. Home administration of IVIG has found increasing favor among treating physicians and their patients.
authors.affiliation: Department of Pediatrics, University of Michigan, Ann Arbor 48109-2029.
authors.forename: S A
authors.initials: SA
authors.lastname: Schwartz
mesh_terms: D000361:Agammaglobulinemia / Q000235:genetics / Q000628:therapy; D005260:Female; D006801:Humans; D017098:IgA Deficiency; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007153:Immunologic Deficiency Syndromes / Q000628:therapy*; D007223:Infant; D008297:Male
chemical_list: D016756:Immunoglobulins, Intravenous